These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 807755)

  • 41. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). II. Background of patients].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):112-29. PubMed ID: 9575438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Frequency of infection and spectrum of type of organisms in neurosurgical cases nursed in intensive care unit (author's transl)].
    Weigel K; Metzel E
    Neurochirurgia (Stuttg); 1974 May; 17(3):107-10. PubMed ID: 4214273
    [No Abstract]   [Full Text] [Related]  

  • 45. Open clinical trial of roxithromycin in patients of Plateau Hospitals, Jos in upper and lower respiratory tract infections.
    Okeke EN; Juryit Z; Ikeh EI
    West Afr J Med; 1995; 14(4):238-41. PubMed ID: 8634230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)].
    Goto H; Takeda H; Kawai S; Watanabe T; Okazaki M; Shimada K; Nakano K; Yokouchi H; Ikemoto H; Mori T; Igari J; Oguri T; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Kudo K; Kobayashi N; Tanaka T; Sumitomo M; Matsushima T; Oka M; Niki Y; Suga M; Tosaka M; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Nasu M; Hiramatsu K; Oikawa S
    Jpn J Antibiot; 2006 Oct; 59(5):323-54. PubMed ID: 17180803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical evaluation of cefpodoxime proxetil, a new oral cephem, in the treatment of respiratory tract infections with the special reference to community-acquired Streptococcus Pneumoniae infections].
    Akiyama O; Ito T; Ogata M; Okano H; Kabe J; Kawakami M; Kida K; Kudo K; Komatsuzaki K; Konno K
    Jpn J Antibiot; 1995 Apr; 48(4):522-8. PubMed ID: 7783315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacterial-viral interrelations in respiratory infections of children.
    Nichol KP; Cherry JD
    N Engl J Med; 1967 Sep; 277(13):667-72. PubMed ID: 4382674
    [No Abstract]   [Full Text] [Related]  

  • 50. [Acute severe mastitis in cows of the Dutch-Friesian Breed (author's transl)].
    Osinga A; Meyer P; Dijkstra RG
    Tijdschr Diergeneeskd; 1976 May; 101(10):548-58. PubMed ID: 818734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1988)].
    Ikemoto H; Watanabe K; Mori T; Hayashi Y; Oguri T; Kondou T; Matsumiya H; Uedi K; Saitou A; Terai T
    Jpn J Antibiot; 1991 Jul; 44(7):770-98. PubMed ID: 1886202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Asian multicenter trial of cefoperazone in respiratory tract infection.
    Matsumoto K; Chung HY; Hsieh WC
    Clin Ther; 1984; 6(6):824-38. PubMed ID: 6391668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Microbiological aspects of the genital flora of bovines (author's transl)].
    Decarlis RM; Moreno G
    Arq Inst Biol (Sao Paulo); 1974; 41(3):95-103. PubMed ID: 4217153
    [No Abstract]   [Full Text] [Related]  

  • 54. New therapeutic perspectives of aminosidine in pneumology. Bacteriological, physiopathological and clinical observations.
    Mariani B; Velluti G; Marchioni CF
    Panminerva Med; 1974; 16(11-12):376-90. PubMed ID: 4463303
    [No Abstract]   [Full Text] [Related]  

  • 55. Sulphenazone sensitivity of some pathogens, and its effect in diseases of the upper respiratory tract.
    Korányi G; Pesti E; Somogyi G
    Acta Paediatr Acad Sci Hung; 1972; 13(3):225-30. PubMed ID: 4631517
    [No Abstract]   [Full Text] [Related]  

  • 56. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)].
    Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical evaluation of sultamicillin in lower respiratory tract infections].
    Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Miyazaki N; Matsuzaki Y
    Jpn J Antibiot; 1991 Feb; 44(2):150-9. PubMed ID: 2041156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Usefulness of ceftazidime in intractable respiratory tract infections].
    Takenaka S; Fukuda K; Kimura T; Shima K; Ushijima M; Egashira Y; Ikeda S; Hiraoka T; Higuchi S; Fujise T
    Jpn J Antibiot; 1989 Dec; 42(12):2555-65. PubMed ID: 2693754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical evaluations of flomoxef in respiratory tract infections].
    Mikasa K; Sawaki M; Ako H; Narita N
    Jpn J Antibiot; 1987 Oct; 40(10):1794-8. PubMed ID: 3444019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies on amikacin (BB-K8), a new aminoglycoside antibiotic (author's transl)].
    Kawano M; Irimajiri K; Higuchi J; Uchiyama T; Tsubura E
    Jpn J Antibiot; 1974 Aug; 27(4):446-50. PubMed ID: 4436954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.